Skip to content

Effects of Two Hypocaloric Diets on Weight Loss

Effects of Two Hypocaloric Diets on Weight Loss and Inflammatory Markers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01312740
Enrollment
13
Registered
2011-03-11
Start date
2007-05-31
Completion date
2008-07-31
Last updated
2011-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

obesity, dietary treatment, high protein diet, Low glycaemic index, adipocytes, fat mass, systemic inflammatory markers, improvement of complications, effect on weight loss

Brief summary

The investigators evaluated whether an energy-restricted protein diet with low glycaemic index carbohydrates and soluble fibers (LC-P-LGI) would be more effective than a conventional diet (LC-CONV) on weight-loss and related metabolic variables.

Detailed description

The subjects (9 men and 5 post-menopausal women) were randomly allocated, in a cross-over design, to two periods of 4 weeks of an energy restricted diet of 1200 kcal as either a conventional diet (LC- CONV) or a special energy restricted diet compensated by proteins (LC-P-LGI). The two nutritional periods were separated by a wash-out interval of 8 weeks. Before the start of the study, all subjects were instructed to maintain their usual lifestyle during the experimental period.Anthropometric parameters, glucose and lipid homeostasis and inflammatory markers were evaluated before and after each dietary period.Body fat and fat-free mass distributions were measured by a dual-energy X-ray absorptiometry (DXA, GE Lunar Prodigy Corporation, Madison, WI, USA) before and after each dietary period at the fasting state.

Interventions

OTHERLC-P-LGI diet

a hypocaloric diet low in lipids (25%) which is compensated by proteins (35%) with no change in carbohydrate content.

OTHERLC-CONV

4-week CONV period consisted in the subjects' consumption of 1200 Kcal/ day (25% protein, 31% lipids, 44% carbohydrates).

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
Pierre and Marie Curie University
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
CollaboratorOTHER
Ceprodi S.A. Kot
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI 26 to 35 Kg/m2 * 25 to 60 years old * non diabetic subjects

Exclusion criteria

* SGOT and SGPT \>2.5x the normal * plasma glucose more than 1.26 g/l * hepatic or renal or cardiac failure

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026